Category: CovidienSyndicate content

Studies: After stroke, clot removal saves brain function

February 11, 2015 by MassDevice

Studies of thrombectomy devices made by Medtronic's Covidien, Stryker and Penumbra show that they dramatically improve the likelihood that patients will recover from stroke.

Studies: After stroke, clot removal saves brain function

(Reuters) - Grabbing and removing a clot blocking blood flow to the brain via thrombectomy, rather than just administering clot-busting drugs, dramatically improves the likelihood that patients will recover from a stroke, according to 2 highly-anticipated studies released today.

MDT's Ev3 pays $1.3m in whistleblower suit | The week in medtech M&A

February 11, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic's new Ev3 unit pays $1.3m in whistleblower suit; GPOs: Premier buys the rest of direct sourcer S2S Global; CareFusion crushes it in final quarter; BD beats Q1 estimates, raises outlook, shares jump; Zimmer revises Biomet bid for EU regulators

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Covidien recalls Trellis clot-busting devices on labeling snafu

February 11, 2015 by Brad Perriello

A labeling miscue prompts Covidien to recall 2 models of its Trellis clot-busting infusion device.

Covidien recalls Trellis clot-busting devices on labeling snafu

UPDATED Feb. 12, 2015, with new information from Medtronic.

Strong 5-year data for Medtronic's ClosureFast varicose vein device

February 10, 2015 by Brad Perriello

Results from a study of Medtronic's ClosureFast varicose vein device, published this month in the British Journal of Surgery, show an 91.9% occlusion rate after 5 years.

Strong 5-year data for Medtronic's ClosureFast varicose vein device

Regulators deal WMGI double whammy | Regulatory news for the week of February 9, 2015

February 10, 2015 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Regulators deal Wright Medical a double whammy; Medtronic wins FDA approval for Melody pulmonary valve; FDA approves Cohera's TissuGlu surgical sealant; FDA approves Medtronic's Pipeline Flex aneurysm device; Sorin wins MRI-safe pacemaker approval in Japan

Regulators deal Wright Medical a double whammy

February 3, 2015 by Brad Perriello

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

February 6, 2015 by Brad Perriello

Medtronic agrees to settle for $1.25 million a whistleblower lawsuit inherited from the Ev3 subsidiary it acquired in the $50 billion Covidien deal.

Medtronic's new Ev3 unit pays $1.3m in whistleblower suit

FDA approves Medtronic's Pipeline Flex aneurysm device

February 5, 2015 by Brad Perriello

The FDA grants pre-market approval for the Pipeline Flex device for treating brain aneurysms Medtronic acquired along with Covidien.

FDA approves Medtronic's Pipeline Flex aneurysm device